AbbVie to acquire Allergan in “transformative move”
Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...
Novartis acquires IFM Tre
Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...
GHO Capital acquires Sterling Pharma Solutions
European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...
Healthtech M&A and IPO Activity
The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...
DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Mundipharma acquires biosimilars development company
The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...
BioIVT acquires CTLS a UK blood donor facility
BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...
Latest articles
Life sciences industry releases COVID-19 testing and diagnostics FAQs
The life sciences industry released a joint statement on COVID-19 testing and diagnostics along with useful COVID-19 testing and diagnostics FAQs. The FAQs have been...
Life sciences’ COVID-19 testing and diagnostics statement
The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Popular articles
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Interim analysis data for Siltuximab-Treated COVID-19 Patients study
An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...
Seqirus starts on-time delivery of NHS flu vaccines
Seqirus has started on-time shipping of its NHS flu vaccines portfolio, FLUAD® (aTIV) and FLUCELVAX® TETRA▼(QIVc), to healthcare professionals across the UK. Delivering Seqirus’ flu...